SECUKINUMAB SIGNFICANTLY IMPROVES THE SIGNS AND SYMPTOMS OF ACTIVE PSORIATIC ARTHRITIS IN PATIENTS PREVIOUSLY EXPOSED TO ANTI-TUMOUR NECROSIS FACTOR THERAPY AND ANTI-TUMOUR NECROSIS FACTOR-NAIVE PATIENTS: 52 WEEK RESULTS FROM THE PHASE III FUTURE 2 TRIAL

被引:0
|
作者
McInnes, Iain [1 ]
Chinoy, Hector [2 ]
Kavanaugh, Arthur [3 ]
Wang, Zailong [4 ]
Mpofu, Shephard [5 ]
机构
[1] Univ Glasgow, Infect Immun & Inflammat, Glasgow, Lanark, Scotland
[2] Univ Manchester, Musculoskeletal Res Inflammat & Repair, Manchester, Lancs, England
[3] Univ Calif San Diego, Sch Med, Innovat Therapy, San Diego, CA 92103 USA
[4] Nova Pharmaceut Corp, Stat, E Hanover, NJ USA
[5] Novartis Pharmaceut, Clin Dev, Basel, Switzerland
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
195
引用
收藏
页码:141 / 141
页数:1
相关论文
共 50 条
  • [31] The impact of escalating conventional therapy in rheumatoid arthritis patients referred for anti-tumour necrosis factor-α therapy
    Bingham, SJ
    Buch, MH
    Tennant, A
    Emery, P
    RHEUMATOLOGY, 2004, 43 (03) : 364 - 368
  • [32] Efficacy and Safety of Anti-Tumour Necrosis Factor in Elderly Patients with Rheumatoid Arthritis: An Observational Study
    Matteo Filippini
    Chiara Bazzani
    Ennio Giulio Favalli
    Antonio Marchesoni
    Fabiola Atzeni
    Piercarlo Sarzi-Puttini
    Francesca Bobbio Pallavicini
    Roberto Caporali
    Roberto Gorla
    Clinical Reviews in Allergy & Immunology, 2010, 38 : 90 - 96
  • [33] Efficacy and Safety of Anti-Tumour Necrosis Factor in Elderly Patients with Rheumatoid Arthritis: An Observational Study
    Filippini, Matteo
    Bazzani, Chiara
    Favalli, Ennio Giulio
    Marchesoni, Antonio
    Atzeni, Fabiola
    Sarzi-Puttini, Piercarlo
    Pallavicini, Francesca Bobbio
    Caporali, Roberto
    Gorla, Roberto
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2010, 38 (2-3) : 90 - 96
  • [34] Anti-tumour necrosis factor treatment in patients with refractory systemic vasculitis associated with rheumatoid arthritis
    Puechal, X.
    Miceli-Richard, C.
    Mejjad, O.
    Lafforgue, P.
    Marcelli, C.
    Solau-Gervais, E.
    Steinfeld, S.
    Villoutreix, C.
    Treves, R.
    Mariette, X.
    Guillevin, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (06) : 880 - 884
  • [35] Anti-tumour necrosis factor alpha therapy improves insulin sensitivity in normal-weight but not in obese patients with rheumatoid arthritis
    Antonios Stavropoulos-Kalinoglou
    Giorgos S Metsios
    Vasileios F Panoulas
    Peter Nightingale
    Yiannis Koutedakis
    George D Kitas
    Arthritis Research & Therapy, 14
  • [36] REVIEW OF PSORIATIC ARTHRITIS IN THE WEST MIDLANDS: ELIGIBILITY FOR ANTI-TUMOUR NECROSIS FACTOR THERAPY UNDER THE NICE GUIDELINES
    Bateman, James
    Cardy, Caroline M.
    Khan, Sophia Y.
    Menon, Ajit
    Obrenovic, Karen
    Rowe, Ian F.
    Erb, Nicola
    RHEUMATOLOGY, 2009, 48 : I57 - I58
  • [37] Anti-tumour necrosis factor alpha therapy improves insulin sensitivity in normal-weight but not in obese patients with rheumatoid arthritis
    Stavropoulos-Kalinoglou, Antonios
    Metsios, Giorgos S.
    Panoulas, Vasileios F.
    Nightingale, Peter
    Koutedakis, Yiannis
    Kitas, George D.
    ARTHRITIS RESEARCH & THERAPY, 2012, 14 (04)
  • [38] Risk of solid cancer in patients exposed to anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis
    Mercer, Louise K.
    Lunt, Mark
    Low, Audrey L. S.
    Dixon, William G.
    Watson, Kath D.
    Symmons, Deborah P. M.
    Hyrich, Kimme L.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (06) : 1087 - 1093
  • [39] LACK OF REPLICATION OF PTPRC GENE AS A PREDICTOR OF RESPONSE TO ANTI-TUMOUR NECROSIS FACTOR THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Canhao, Helena
    Rodrigues, Ana
    Santos, Maria Jose
    Carmona-Fernandes, Diana
    Costa, Jose
    Santos, Helena
    Branco, Jaime
    Plenge, Robert
    Solomon, Daniel
    Armas, Jacome
    Silva, Jose Antonio
    Fonseca, Joao Eurico
    Karlson, Elizabeth
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : A53 - A53
  • [40] Long-term retention rates of anti-tumour necrosis factor and anti-interleukin-17 antibodies for patients with psoriatic arthritis
    Takami, Kenji
    Tsuji, Shigeyoshi
    Sato, Sachina
    Akaji, Kazuya
    Yamashita, Chigusa
    Hiroumi, Shiori
    Konaka, Hachiro
    Hayashi, Misa
    Higashiyama, Mari
    MODERN RHEUMATOLOGY, 2023, 34 (05) : 1013 - 1018